Tag: Pfizer

Discussions on with India for ‘expedited approval’ of Covid-19 vaccine: Pfizer

NEW DELHI: Global Pharma major Pfizer is discussing with the Indian government an expedited approval pathway to make Pfizer-BioNTech vaccine available for use in the country, the company’s Chairman and CEO Albert Bourla said on Monday. Earlier in April, Pfizer said that it had offered a not-for-profit price for its vaccine for the government immunisation […]

Covid-19 vaccine 3rd dose ‘likely’ needed within 12 months: Pfizer

The head of Pfizer said in an interview aired Thursday that people will “likely” need a third dose of his company’s Covid-19 vaccine within a year of being fully vaccinated. CEO Albert Bourla also said annual vaccinations against the coronavirus may well be required. “We need to see what would be the sequence, and for […]

Pfizer withdraws emergency use bid of its COVID-19 vaccine in India

NEW DELHI: Pfizer Inc has withdrawn an application for emergency-use authorisation of its COVID-19 vaccine in India that it has developed with Germany’s BioNTech, the company told the Reuters news agency on Friday. The United States company, which was the first drugmaker to apply for emergency use authorisation of its COVID-19 vaccine in India, had […]

WHO recommends two doses of Pfizer COVID-19 vaccine within 21-28 days

GENEVA: COVID-19 patients should take two doses of the new Pfizer/BioNTech vaccine within a period of 21-28 days, the head of the World Health Organization’s immunization advisory group said on Tuesday. “We deliberated and came out with the following recommendation: two 2 doses of this vaccine within 21-28 days,” Alejandro Cravioto, chairman of WHO’s Strategic […]

After Pfizer, US Approves Moderna COVID-19 Vaccine

NEW DELHI: The US biotechnology company Moderna has announced that the U.S. Food and Drug Administration’s (FDA) has authorized the emergency use of mRNA-1273, Moderna’s vaccine against COVID-19 in individuals 18 years of age or older. The Moderna approval comes exactly a week after the US Food and Drug Administration okay-ed a shot from Pfizer […]

Singapore approves Pfizer’s COVID-19 vaccine in Asia first

By John Geddie, Anshuman Daga SINGAPORE: Singapore became on Monday the first Asian country to approve Pfizer-BioNTech’s coronavirus vaccine and said it expects to start receiving shots by the end of the year. Prime Minister Lee Hsien Loong, 68, said he would be among the early recipients in the city-state of 5.7 million people, which […]

Pfizer COVID-19 vaccine shipments begin in historic US effort

By MATTHEW PERRONE, MIKE STOBBE and MORRY GASH KALAMAZOO:The first shipments of a COVID-19 vaccine for widespread use in the United States headed Sunday from Michigan to distribution centers across the country, with the first shots expected to be given in the coming week to health care workers and at nursing homes. Shipments of the […]

What’s next for Pfizer’s COVID-19 vaccine after UK rollout

Britain began the mass-vaccination of its population against COVID-19 on Tuesday, becoming the first Western nation to do so in a global endeavour that poses one of the biggest logistical challenges in peacetime history. Margaret Keenan, a 90-year-old grandmother from Britain, became the first person in the world to receive the Pfizer vaccine outside of […]

US allows Pfizer COVID-19 vaccine; Donald Trump says it will be free for all Americans

By LAURAN NEERGAARD, MATTHEW PERRONE and JONATHAN LEMIRE WASHINGTON: The U.S. gave the final go-ahead Friday to the nation’s first COVID-19 vaccine, marking what could be the beginning of the end of an outbreak that has killed nearly 300,000 Americans. Shots for health workers and nursing home residents are expected to begin in the coming […]

Can I stop wearing a mask after getting a COVID-19 vaccine?

Can I stop wearing a mask after getting a COVID-19 vaccine? No. For a couple reasons, masks and social distancing will still be recommended for some time after people are vaccinated. To start, the first coronavirus vaccines require two shots; Pfizer’s second dose comes three weeks after the first and Moderna’s comes after four weeks. […]

Pfizer COVID-19 vaccine faces last hurdle before US decision

By LAURAN NEERGAARD and MATTHEW PERRONE WASHINGTON: Pfizer’s COVID-19 vaccine faces one final hurdle as it races to become the first shot greenlighted in the U.S.: a panel of experts who will scrutinize the company’s data for any red flags. Thursday’s meeting of the Food and Drug Administration’s vaccine advisory panel is likely the last […]

When and which COVID-19 vaccines are likely to be available in Asia

NEW DELHI: Pfizer Inc with partner BioNTech SE, Moderna Inc and AstraZeneca Plc have released trial data this month showing their experimental vaccines are effective in preventing the disease. If regulators approve any of the vaccines in coming weeks, the companies have said distribution could begin almost immediately with governments around the world. But many […]

Russia’s Sputnik V Covid-19 vaccine single dose can be less than $10 at international markets

By DARIA LITVINOVA MOSCOW: Russia released new results Tuesday claiming its experimental COVID-19 vaccine was highly effective, and promised it would cost less on international markets than vaccines by some of its Western competitors. According to the Russian Direct Investment Fund, which bankrolled the development of the jab, Sputnik V will cost less than $10 […]

Q&A: Where are we in the COVID-19 vaccine race?

NEW DELHI: Drug makers and research centres around the world are working on COVID-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants well underway. The following is what we know about the race to deliver vaccines to help end the coronavirus pandemic that has claimed more than […]

Pfizer, BioNTech plan emergency move to use Covid-19 vaccine

NEW DELHI: Pfizer and BioNTech SE (Nasdaq: BNTX) announced they will submit a request today to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their mRNA vaccine candidate, BNT162b2 against SARS-CoV-2, which will potentially enable use of the vaccine in high-risk populations in the U.S. by the middle to end […]

Back To Top